Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 04 - 28    tags : Phase 1    save search

Zai Lab and Turning Point Therapeutics Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study
Published: 2022-04-28 (Crawled : 21:00) - globenewswire.com
ZLAB | $15.61 3.24% 190K twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 1.33% C: -7.14%
TPTX | $76.01 -0.03% twitter stocktwits trandingview |
Health Technology
| | O: 2.89% H: 0.0% C: -3.26%

topline therapeutics china phase 1
Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
SKYE | $13.1 -6.63% 15K twitter stocktwits trandingview |
Transportation and Warehousing
| | O: -4.86% H: 7.1% C: 3.69%

research trial bioscience phase 1
Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
VAXX | $0.166 -17.0% 990K twitter stocktwits trandingview |
| | O: -1.94% H: 8.76% C: 6.5%

ub-312 disease trial enroll phase 1
Alzamend Neuro Announces $4 Million Additional Investment from Digital Power Lending Upon Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
NILE 4 | $0.1225 0.0% twitter stocktwits trandingview |
n/a
| | O: -2.93% H: 3.88% C: 0.64%
ALZN | $0.7256 7.3K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 5.59% H: 1.6% C: -2.25%

al001 treatment dementia trial alzheimer’s phase 1 alzheimer's
BitNile Holdings Announces Additional Investment in Alzamend From Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
NILE 4 | $0.1225 0.0% twitter stocktwits trandingview |
n/a
| | O: -2.93% H: 3.88% C: 0.64%
ALZN | $0.7256 7.3K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 5.59% H: 1.6% C: -2.25%

al001 treatment dementia trial alzheimer’s phase 1 alzheimer's
Gainers vs Losers
54% 46%

Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.04 121.24% 9.6M twitter stocktwits trandingview |

BOF | $2.05 75.21% 78M twitter stocktwits trandingview |

AMST | $3.2 60.0% 63M twitter stocktwits trandingview |
Technology Services

LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.05 44.75% 13M twitter stocktwits trandingview |
Technology Services

TROO | $1.51 38.53% 5.6M twitter stocktwits trandingview |
Manufacturing

MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information

RILY | $27.91 28.5% 8.9M twitter stocktwits trandingview |
Finance

WHLM | $6.43 26.58% 580K twitter stocktwits trandingview |
Commercial Services


Your saved searches
Save your searches and get alerts when important news are released.